Dr. René Riedel and Stephen Lepore from the University of California, Riverside have developed an NMR tube/reactor that enables in-situ irradiation to photo-initiate reactions in an inert or controlled atmosphere. It allows for the data acquisition of air, moisture, and temperature-sensitive liquid samples by nuclear magnetic resonance (NMR) spectroscopy without needing to remove the sample from the spectrometer for irradiation. This technology is advantageous because it makes photochemical reactions and kinetic measurements of sensitive samples more reproducible, and it enables the previously impossible maintenance of a controlled environment during photochemical NMR investigations.

 Professors Richard Schrock, Matthew Conley, and colleagues from the University of California, Riverside have developed a new Schrock catalysts for olefin metathesis that can be produced in fewer synthetic steps, activated with perfluorinated alcohols, and reactivated using light or heat. The method provides a more convenient route to a variety of Schrock catalysts that avoid corrosive triflic acid and reactive Grignard reagents to yield Schrock catalysts, which can then be converted readily into other catalyst variations. This technology is advantageous because it is a safer and less expensive way to synthesize and activate Schrock catalysts for industrial and research applications.  

Professor Xiaoping Hu’s lab at the University of California, Riverside has developed a novel method that allows creatine to bypass the BBB and directly reach the brain. The technology works by delivering creatine intranasally using microparticles. These creatine particles have shown to not exhibit cytotoxicity, are highly stable, and are not disruptive to cell barriers. This technology is advantageous over traditional creatine monohydrate and anhydrous creatine because the smaller particle size ensures even distribution and greater permeability across the BBB. 

Brief description not available

Professor Hideaki Tsutsui and colleagues from the University of California, Riverside have developed a portable handheld device for nucleic acid extraction. With its high-speed motor, knurled lysis chamber for rapid sample lysis, and quick nucleic acid extraction using paper disks, this device can yield ready-to-use extracts in just 12 minutes, significantly reducing the time required for sample preparation. This technology is advantageous over current methods as it can be expedited without the need for cumbersome specimen collection, packaging, and submission, shortening the turnaround time.  

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Professor Thomas Kuhlman and colleagues from the University of California, Riverside have developed a novel method named “Chemical Selectivity Readouts” and FRET sensor that can be used to identify new p38 MAPK inhibitors for development. Chemical Selectivity Readouts work by measuring p38 MAPK inhibition through the detection of resonance selectivity by Fourier transform. This technology is advantageous because it can enable the research and development of new and improved drugs targeting p38 MAPK for specific diseases like cancer and neurological disorders.  Past clinical development roadblocks can be overcome with this new assay by developing more specific and less toxic drugs.  

Brief description not available

The University of California, Riverside has developed a new omics software named, ShowMEPATH, employing a faster and easier approach to compare changes in metabolites within multiple sample groups, along with an automated algorithm to facilitate the process. The software introduces a novel tool to visualize volcano plots, called Parallel Fold Change (PFC) plot. Unlike current software solutions, PFC enables researchers to easily process their large omics data sets to compare various biological networks. The PFC plot is an efficient tool for analyzing and interpreting complex biological comparisons and it helps researchers to efficiently map omics pathways.  Fig 1: This figure illustrates a Parallel Fold Change (PFC) plot and demonstrates the parallel comparison of multiple samples in metabolomics. The tool examines the fold-change patterns of 45 metabolites across 16 scenarios involving 8 genotypes and 3 treatments. Using ShowMEPATH, researchers can identify detailed patterns within biological experiments, with the ability to hover over lines in the PFC plots for seamless access to KEGG modules or pathways, thereby streamlining the exploration of related biological information 

Professors Richard Schrock, Matthew Conley, and colleagues from the University of California, Riverside have developed new Schrock catalysts in the form of tungsten cyclohexylidenes that can be produced in as few as three synthetic steps, using inexpensive and non-corrosive reagents. This technology forms metathesis-relevant alkylidenes from an olefin through a novel thermal mechanism that avoids a protonation/deprotonation mechanism. This technology is advantageous because it can enable a cost-effective access to metathesis active Schrock catalysts for industrial and research applications. 

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Prof. John Franchak and his team have developed a prototype system that accurately classifies an infant's body position.